Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Galectin-4 expression in carcinoid tumors.

Kandelaria M Rumilla1, Lori A Erickson, Alan K Erickson

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Endocrine Pathology
|February 20, 2007
PubMed
Summary

Galectin-4 (Gal-4) shows varied expression in carcinoid tumors, being most prominent in ileal tumors. This study investigates Gal-4 distribution across different tumor locations, revealing distinct patterns in the gastrointestinal tract and lungs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report of thirteen non-conventional FLCN-mutated (renal) tumors (FMT) and a discussion of proposed diagnostic criteria, convergent FLCN/TFEB and FLCN/MITF E318K signaling, and FLCN immunohistochemistry.

Human pathology·2026
Same author

DICER1 Syndrome-Associated Thyroid Follicular Nodular Disease.

Mayo Clinic proceedings·2026
Same author

DDX5::TFEB-Rearranged Melanotic PEComa.

Mayo Clinic proceedings·2026
Same author

Xanthogranulomatous Epithelial Tumor/Keratin-Positive Giant Cell-Rich Soft Tissue Tumor.

Mayo Clinic proceedings·2026
Same author

Clinical and genetic characterization of constitutional MLH1 promoter hypermethylation: Implications for Lynch syndrome diagnosis.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

The RESILIENT Study: A Retrospective, Descriptive, Correlational Investigation of Correlates of Oral Endocrine Therapy Adherence in Older Women With Breast Cancer.

Cancer medicine·2026

Area of Science:

  • Carcinogenesis and Oncology
  • Molecular Biology
  • Immunohistochemistry

Background:

  • Galectins (Gal) are carbohydrate-binding proteins involved in inflammation and tumor progression.
  • Galectin-4 (Gal-4) expression is less understood compared to Gal-1 and Gal-3.
  • Previous research localized Gal-4 in the enterochromaffin cells of the small intestine.

Purpose of the Study:

  • To examine Galectin-4 expression in human carcinoid tumors from various sites.
  • To compare Gal-4 distribution in primary versus metastatic ileal carcinoid tumors.
  • To investigate the presence of Gal-1 and Gal-3 alongside Gal-4 in these tumors.

Main Methods:

  • Immunohistochemistry on tissue microarrays (TMA) and larger tissue sections.
  • Monoclonal antibodies against Gal-4, Gal-3, and Gal-1 were utilized.

Related Experiment Videos

  • Western blot analysis was performed on ileal carcinoid samples.

    • Main Results:

    • Galectin-4 was highly expressed in ileal carcinoid tumors, with higher levels in primary compared to metastatic.
    • Gastric carcinoids also showed Gal-4 expression, while pulmonary and rectal carcinoids had minimal expression.
    • Pancreatic neuroendocrine tumors were negative for Gal-1, Gal-3, and Gal-4. Gal-3 and Gal-1 were not detected in metastatic ileal carcinoids via Western blot.

    Conclusions:

    • Galectin-4 exhibits differential expression patterns in carcinoid tumors based on anatomical location.
    • Ileal and gastric carcinoids show significant Gal-4 presence, unlike pulmonary and rectal carcinoids.
    • Findings suggest a specific role for Gal-4 in ileal carcinoid tumorigenesis.